tiprankstipranks
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
Holding CRBP?
Track your performance easily

Corbus Pharmaceuticals (CRBP) Financial Statements

2,321 Followers

Corbus Pharmaceuticals Financial Overview

Corbus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.695; its P/E ratio is -3.82; Corbus Pharmaceuticals is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-1.24. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -14.97M$ -10.25M$ -7.05M$ -10.71M$ -9.29M
EBITDA$ -14.74M$ -9.97M$ -6.71M$ -10.56M$ -9.14M
Net Income Common Stockholders$ -13.78M$ -10.06M$ -6.90M$ -8.02M$ -10.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 159.36M$ 147.03M$ 120.10M$ 20.91M$ 28.73M
Total Assets$ 164.17M$ 151.98M$ 125.74M$ 28.27M$ 36.28M
Total Debt$ 3.61M$ 14.80M$ 17.29M$ 20.88M$ 22.86M
Net Debt$ -155.75M$ -132.23M$ -102.82M$ -21.77K$ -5.88M
Total Liabilities$ 13.67M$ 26.44M$ 28.78M$ 35.18M$ 35.97M
Stockholders Equity$ 150.50M$ 125.52M$ 96.97M$ -6.90M$ 311.02K
Cash Flow-
Free Cash Flow$ -13.94M$ -8.94M$ -7.97M$ -6.01M$ -7.18M
Operating Cash Flow$ -13.94M$ -8.94M$ -7.97M$ -6.01M$ -7.18M
Investing Cash Flow$ -15.37M$ -16.44M$ -98.24M$ 10.39M$ 10.90M
Financing Cash Flow$ 25.04M$ 34.96M$ 106.58M$ -1.90M$ -820.50K
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

Corbus Pharmaceuticals Debt to Assets

Corbus Pharmaceuticals Cash Flow

Corbus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis